Guigao Lin

1.6k total citations
71 papers, 1.2k citations indexed

About

Guigao Lin is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Guigao Lin has authored 71 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 21 papers in Epidemiology and 13 papers in Infectious Diseases. Recurrent topics in Guigao Lin's work include CRISPR and Genetic Engineering (11 papers), Hepatitis B Virus Studies (8 papers) and Cancer Genomics and Diagnostics (7 papers). Guigao Lin is often cited by papers focused on CRISPR and Genetic Engineering (11 papers), Hepatitis B Virus Studies (8 papers) and Cancer Genomics and Diagnostics (7 papers). Guigao Lin collaborates with scholars based in China, United States and United Kingdom. Guigao Lin's co-authors include Jinming Li, Rongxue Peng, Yanxi Han, Kuo Zhang, Lunan Wang, Kuo Zhang, Xuexiang Li, Jun Qi, Yu Sun and Minjie Wang and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Guigao Lin

67 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guigao Lin China 17 688 320 177 135 127 71 1.2k
Matthew C. Biery United States 17 1.0k 1.5× 500 1.6× 151 0.9× 218 1.6× 62 0.5× 29 1.6k
Daniel C. Edelman United States 17 393 0.6× 121 0.4× 133 0.8× 75 0.6× 62 0.5× 34 903
M. Nedim Ince United States 13 924 1.3× 250 0.8× 198 1.1× 257 1.9× 90 0.7× 23 1.6k
Robert K. Bright United States 22 670 1.0× 202 0.6× 80 0.5× 174 1.3× 39 0.3× 60 1.5k
Karen J. Mackenzie United Kingdom 13 974 1.4× 171 0.5× 234 1.3× 77 0.6× 25 0.2× 15 1.9k
Alessia Covre Italy 20 1.1k 1.5× 190 0.6× 127 0.7× 98 0.7× 52 0.4× 51 2.0k
Kasinath Viswanathan United States 16 431 0.6× 95 0.3× 446 2.5× 99 0.7× 36 0.3× 26 1.3k
Mingjin Yang China 19 849 1.2× 337 1.1× 131 0.7× 47 0.3× 24 0.2× 26 1.5k
Jérôme Bouchet France 22 846 1.2× 256 0.8× 162 0.9× 71 0.5× 23 0.2× 35 1.6k
James M. Sodetz United States 26 702 1.0× 228 0.7× 89 0.5× 95 0.7× 22 0.2× 65 2.0k

Countries citing papers authored by Guigao Lin

Since Specialization
Citations

This map shows the geographic impact of Guigao Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guigao Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guigao Lin more than expected).

Fields of papers citing papers by Guigao Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guigao Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guigao Lin. The network helps show where Guigao Lin may publish in the future.

Co-authorship network of co-authors of Guigao Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Guigao Lin. A scholar is included among the top collaborators of Guigao Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guigao Lin. Guigao Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Kuo, et al.. (2024). CRISPR‐Cas system: A promising tool for rapid detection of SARS‐CoV‐2 variants. Journal of Medical Virology. 96(1). e29356–e29356. 9 indexed citations
2.
Zhang, Kuo, Guigao Lin, Yanxi Han, Rongxue Peng, & Jinming Li. (2023). Analysis of Clinical Laboratory Detecting Challenging Variants from Exome Sequencing Using Simulated Patient–Parent Trio Sample. Journal of Molecular Diagnostics. 25(6). 378–387.
3.
Lin, Guigao, Kuo Zhang, Yanxi Han, et al.. (2022). Reprogramming of Human B Cells from Secreting IgG to IgM by Genome Editing. The CRISPR Journal. 5(5). 717–725. 1 indexed citations
4.
Peng, Rongxue, Guigao Lin, Lin Li, & Jinming Li. (2022). Development of a Novel Reference Material for Tumor Mutational Burden Measurement Based on CRISPR/Cas9 Technology. Frontiers in Oncology. 12. 845636–845636. 2 indexed citations
5.
Zhang, Kuo, Guigao Lin, & Jinming Li. (2022). Carrier screening: An update. Clinica Chimica Acta. 535. 92–98. 1 indexed citations
6.
Zhang, Kuo, Guigao Lin, Dongsheng Han, et al.. (2022). Adaptation of ACMG-ClinGen Technical Standards for Copy Number Variant Interpretation Concordance. Frontiers in Genetics. 13. 829728–829728. 7 indexed citations
7.
Zhang, Xiao, Guigao Lin, Liming Tan, & Jinming Li. (2018). Current progress of tacrolimus dosing in solid organ transplant recipients: Pharmacogenetic considerations. Biomedicine & Pharmacotherapy. 102. 107–114. 27 indexed citations
8.
Peng, Rongxue, Guigao Lin, Xin Yang, et al.. (2017). CRISPR/Cas9 Technology–Based Xenograft Tumors as Candidate Reference Materials for Multiple EML4-ALK Rearrangements Testing. Journal of Molecular Diagnostics. 19(5). 766–775. 7 indexed citations
9.
Zhang, Kuo, Guigao Lin, Yanxi Han, Jiehong Xie, & Jinming Li. (2017). Circulating unmethylated insulin DNA as a potential non-invasive biomarker of beta cell death in type 1 Diabetes: a review and future prospect. Clinical Epigenetics. 9(1). 44–44. 16 indexed citations
10.
Li, Yulong, Yanxi Han, Lu Tian, et al.. (2016). Comparison of the types of candidate reference samples for quality control of human epidermal growth factor receptor 2 status detection. Diagnostic Pathology. 11(1). 85–85. 7 indexed citations
11.
Liu, Chao, Le Chang, Huimin Ji, et al.. (2016). Prevalence of HBV DNA among 20 million seronegative blood donations in China from 2010 to 2015. Scientific Reports. 6(1). 36464–36464. 10 indexed citations
12.
Lin, Guigao, Kuo Zhang, Lunan Wang, et al.. (2015). Implementation of Cell Samples as Controls in National Proficiency Testing for Clopidogrel Therapy-Related CYP2C19 Genotyping in China: A Novel Approach. PLoS ONE. 10(7). e0134174–e0134174. 3 indexed citations
13.
Chen, Li‐Da, Wenli Li, Kuo Zhang, et al.. (2015). Hepatitis C Virus RNA Real-Time Quantitative RT-PCR Method Based on a New Primer Design Strategy. Journal of Molecular Diagnostics. 18(1). 84–91. 12 indexed citations
14.
Zhang, Dong, Yu Sun, Tingting Jia, et al.. (2015). External Quality Assessment for the Detection of Measles Virus by Reverse Transcription-PCR Using Armored RNA. PLoS ONE. 10(8). e0134681–e0134681. 15 indexed citations
15.
Sun, Yu, Guigao Lin, Rui Zhang, et al.. (2012). Multicolor flow cytometry analysis of the proliferations of T‐lymphocyte subsets in vitro by EdU incorporation. Cytometry Part A. 81A(10). 901–909. 24 indexed citations
16.
Lin, Guigao & Jinming Li. (2010). Elevation of serum IgG subclass concentration in patients with rheumatoid arthritis. Rheumatology International. 30(6). 837–840. 26 indexed citations
17.
Lin, Guigao & Jinming Li. (2009). IgG subclass serum levels in systemic lupus erythematosus patients. Clinical Rheumatology. 28(11). 1315–1318. 22 indexed citations
18.
Lin, Guigao & Jinming Li. (2009). Sequence Identity between the Genomes of Humans and Viruses. Intervirology. 52(4). 196–200. 4 indexed citations
19.
20.
Wei, Baojun, Yuxiang Wei, Kuo Zhang, et al.. (2008). Development of an antisense RNA delivery system using conjugates of the MS2 bacteriophage capsids and HIV-1 TAT cell penetrating peptide. Biomedicine & Pharmacotherapy. 63(4). 313–318. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthew C. Biery Breakdown of academic impact, for papers by Daniel C. Edelman Breakdown of academic impact, for papers by M. Nedim Ince Breakdown of academic impact, for papers by Robert K. Bright Breakdown of academic impact, for papers by Karen J. Mackenzie Breakdown of academic impact, for papers by Alessia Covre Breakdown of academic impact, for papers by Kasinath Viswanathan Breakdown of academic impact, for papers by Mingjin Yang Breakdown of academic impact, for papers by Jérôme Bouchet Breakdown of academic impact, for papers by James M. Sodetz
Rankless by CCL
2026